Target lesions with greater precision
Fuse MRI and ultrasound imaging to create a new level of accuracy when templating and targeting suspicious prostate lesions

MR Fusion Solution
Targeted MR/US fusion biopsy is poised to become the procedure of choice in the detection and management of prostate cancer. Pre-exam MRI prostate images fused with real-time ultrasound create 3D high-definition color imaging that helps physicians accurately target visible lesions during biopsy.

Outcome
Each offering is designed around flexible deployment, dependable support, and predictable operational performance
Fuse MRI and ultrasound imaging to create a new level of accuracy when templating and targeting suspicious prostate lesions
Give physicians a 3D view of prostate anatomy and lesions in real time while performing targeted biopsy procedures
Support evaluation of patients with unexplained high or rising PSAs and-or abnormal DRE findings using advanced fusion-guided imaging
Deployment
The delivery model stays focused on reducing complexity while helping facilities and physicians maintain procedural access
Conventional TRUS biopsy is considered a blind approach because physicians cannot see the specific location of abnormal tissue during sampling
The Eigen Artemis 3D Navigation System combined with Hitachi Noblus Ultrasound provides a highly accurate method for early detection, diagnosis, and monitoring of prostate cancer
A semi-robotic arm supports accurate image reproduction while minimizing prostate deformation during biopsy
Equipment is delivered, set up, and prepared by an experienced UMS technologist who remains on site to support reliable operation throughout the procedure
Flexible scheduling with mobile access helps facilities add advanced capability without capital expenditures
Partnership opportunities are available for providers expanding prostate imaging and biopsy programs
Next step
Talk with the team about how this solution can help your facility increase utilization and simplify service delivery